Biotricity Inc.
(BTCY)
undefined
undefined%
At close: undefined
0.43
43.71%
After-hours Aug 02, 2024, 07:58 PM EDT
Company Description
Biotricity, Inc., a medical technology company, provides biometric data monitoring solutions primarily in the United States.
The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses.
It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components.
The company is based in Redwood City, California.
Biotricity Inc.
| Country | United States |
| IPO Date | Feb 16, 2018 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 55 |
| CEO | Dr. Waqaas Al-Siddiq Ph.D. |
Contact Details
Address: 275 Shoreline Drive Redwood City, California United States | |
| Website | https://www.biotricity.com |
Stock Details
| Ticker Symbol | BTCY |
| Exchange | NASDAQ |
| Fiscal Year | April - March |
| Reporting Currency | USD |
| CIK Code | 0001630113 |
| CUSIP Number | 09074H104 |
| ISIN Number | US09074H2031 |
| Employer ID | 47-2548273 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Dr. Waqaas Al-Siddiq Ph.D. | Founder, President, Chief Executive Officer & Chairman |
| S. John Ayanoglou | Chief Financial Officer |
| Amir Ali | Chief Development Officer |
| Amjad Talpur | Senior Director of Operations |
| Dr. Fareeha Siddiqui | Executive Vice President of Healthcare Solutions |
| Matt Zabel | Vice President of Sales & Strategy |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 20, 2024 | 8-K | Current Report |
| Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Nov 14, 2024 | 10-Q | Quarterly Report |
| Oct 15, 2024 | 25-NSE | Filing |
| Aug 19, 2024 | 10-Q | Quarterly Report |
| Aug 16, 2024 | 8-K | Current Report |
| Aug 15, 2024 | NT 10-Q | Filing |
| Aug 08, 2024 | SC 13G | Statement of acquisition of beneficial ownership b... |
| Aug 07, 2024 | 8-K | Current Report |
| Aug 05, 2024 | DEF 14A | Filing |